Neutrophil CD64 expression distinguishing acute inflammatory autoimmune disease from systemic infections

Antony C. Bakke, Everett Allen, M. Zoe Purtzer, Atulya (Atul) Deodhar

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Common bacterial and opportunistic infections are a major cause of mortality in patients who are immunosuppressed due to treatment with corticosteroids or cytotoxic drugs. Common laboratory tests for infection lack sensitivity and specificity. Therefore a new generation of tests to detect early systemic infections has been suggested. One of these tests measures the up-regulation of a Fc receptor (Fcγ R1, or CD 64) on neutrophils. The Fc receptors on white blood cells are very important for effective phagocytosis of bacteria and are up-regulated during an infection. The clinical utility of quantitative CD64 measurements to differentiate between systemic infection and active autoimmune inflammation was examined in an ongoing study. Patients with systemic infection (n = 26), patients with active autoimmune inflammatory disease (n = 45), patients with vasculitis (n = 4) and controls (n = 20) were studied for neutrophil CD64 expression using monoclonal antibodies and flow cytometry. Results from this study concluded that CD64 is up-regulated in systemic infections and some localized infections. Some cases of infection can demonstrate low to intermediate levels of CD64 due to species of bacteria, localized infection and/or length of antibiotic therapy. Ninety-two percent of uninfected patients bind 2000 CD64 antibodies. These results together with other published studies indicate that quantitative measurement of CD64 is very promising for detection of systemic infection.

Original languageEnglish (US)
Pages (from-to)267-275
Number of pages9
JournalClinical and Applied Immunology Reviews
Volume1
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Autoimmune Diseases
Neutrophils
Infection
Fc Receptors
Laboratory Infection
Bacteria
Opportunistic Infections
Vasculitis
Phagocytosis
Bacterial Infections
Flow Cytometry
Adrenal Cortex Hormones
Leukocytes
Up-Regulation
Monoclonal Antibodies
Anti-Bacterial Agents
Inflammation
Sensitivity and Specificity
Mortality
Antibodies

Keywords

  • CD64
  • Fc receptor
  • Flow cytometry
  • Neutrophil

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Neutrophil CD64 expression distinguishing acute inflammatory autoimmune disease from systemic infections. / Bakke, Antony C.; Allen, Everett; Purtzer, M. Zoe; Deodhar, Atulya (Atul).

In: Clinical and Applied Immunology Reviews, Vol. 1, No. 5, 2001, p. 267-275.

Research output: Contribution to journalArticle

@article{3180c65127464ad78ecf3ea62212c223,
title = "Neutrophil CD64 expression distinguishing acute inflammatory autoimmune disease from systemic infections",
abstract = "Common bacterial and opportunistic infections are a major cause of mortality in patients who are immunosuppressed due to treatment with corticosteroids or cytotoxic drugs. Common laboratory tests for infection lack sensitivity and specificity. Therefore a new generation of tests to detect early systemic infections has been suggested. One of these tests measures the up-regulation of a Fc receptor (Fcγ R1, or CD 64) on neutrophils. The Fc receptors on white blood cells are very important for effective phagocytosis of bacteria and are up-regulated during an infection. The clinical utility of quantitative CD64 measurements to differentiate between systemic infection and active autoimmune inflammation was examined in an ongoing study. Patients with systemic infection (n = 26), patients with active autoimmune inflammatory disease (n = 45), patients with vasculitis (n = 4) and controls (n = 20) were studied for neutrophil CD64 expression using monoclonal antibodies and flow cytometry. Results from this study concluded that CD64 is up-regulated in systemic infections and some localized infections. Some cases of infection can demonstrate low to intermediate levels of CD64 due to species of bacteria, localized infection and/or length of antibiotic therapy. Ninety-two percent of uninfected patients bind 2000 CD64 antibodies. These results together with other published studies indicate that quantitative measurement of CD64 is very promising for detection of systemic infection.",
keywords = "CD64, Fc receptor, Flow cytometry, Neutrophil",
author = "Bakke, {Antony C.} and Everett Allen and Purtzer, {M. Zoe} and Deodhar, {Atulya (Atul)}",
year = "2001",
doi = "10.1016/S1529-1049(01)00029-0",
language = "English (US)",
volume = "1",
pages = "267--275",
journal = "Clinical and Applied Immunology Reviews",
issn = "1529-1049",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Neutrophil CD64 expression distinguishing acute inflammatory autoimmune disease from systemic infections

AU - Bakke, Antony C.

AU - Allen, Everett

AU - Purtzer, M. Zoe

AU - Deodhar, Atulya (Atul)

PY - 2001

Y1 - 2001

N2 - Common bacterial and opportunistic infections are a major cause of mortality in patients who are immunosuppressed due to treatment with corticosteroids or cytotoxic drugs. Common laboratory tests for infection lack sensitivity and specificity. Therefore a new generation of tests to detect early systemic infections has been suggested. One of these tests measures the up-regulation of a Fc receptor (Fcγ R1, or CD 64) on neutrophils. The Fc receptors on white blood cells are very important for effective phagocytosis of bacteria and are up-regulated during an infection. The clinical utility of quantitative CD64 measurements to differentiate between systemic infection and active autoimmune inflammation was examined in an ongoing study. Patients with systemic infection (n = 26), patients with active autoimmune inflammatory disease (n = 45), patients with vasculitis (n = 4) and controls (n = 20) were studied for neutrophil CD64 expression using monoclonal antibodies and flow cytometry. Results from this study concluded that CD64 is up-regulated in systemic infections and some localized infections. Some cases of infection can demonstrate low to intermediate levels of CD64 due to species of bacteria, localized infection and/or length of antibiotic therapy. Ninety-two percent of uninfected patients bind 2000 CD64 antibodies. These results together with other published studies indicate that quantitative measurement of CD64 is very promising for detection of systemic infection.

AB - Common bacterial and opportunistic infections are a major cause of mortality in patients who are immunosuppressed due to treatment with corticosteroids or cytotoxic drugs. Common laboratory tests for infection lack sensitivity and specificity. Therefore a new generation of tests to detect early systemic infections has been suggested. One of these tests measures the up-regulation of a Fc receptor (Fcγ R1, or CD 64) on neutrophils. The Fc receptors on white blood cells are very important for effective phagocytosis of bacteria and are up-regulated during an infection. The clinical utility of quantitative CD64 measurements to differentiate between systemic infection and active autoimmune inflammation was examined in an ongoing study. Patients with systemic infection (n = 26), patients with active autoimmune inflammatory disease (n = 45), patients with vasculitis (n = 4) and controls (n = 20) were studied for neutrophil CD64 expression using monoclonal antibodies and flow cytometry. Results from this study concluded that CD64 is up-regulated in systemic infections and some localized infections. Some cases of infection can demonstrate low to intermediate levels of CD64 due to species of bacteria, localized infection and/or length of antibiotic therapy. Ninety-two percent of uninfected patients bind 2000 CD64 antibodies. These results together with other published studies indicate that quantitative measurement of CD64 is very promising for detection of systemic infection.

KW - CD64

KW - Fc receptor

KW - Flow cytometry

KW - Neutrophil

UR - http://www.scopus.com/inward/record.url?scp=3142558289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142558289&partnerID=8YFLogxK

U2 - 10.1016/S1529-1049(01)00029-0

DO - 10.1016/S1529-1049(01)00029-0

M3 - Article

VL - 1

SP - 267

EP - 275

JO - Clinical and Applied Immunology Reviews

JF - Clinical and Applied Immunology Reviews

SN - 1529-1049

IS - 5

ER -